ADMA ADMA Biologics
ADMA Biologics earnings company data as of 4:45 AM ET 11/6
- 1 of 1 EPS beats
History
1 period, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 4 Nov | EPS | 0.19 | 0.22 | Beat +15.8% |
| Rev | $138.1M | $141.1M | Beat +2.2% |
Insider trades
Open-market buys and sales by ADMA's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $468K bought by 2 insiders
- $158K sold by 1 insider outside a trading plan
- $3.2M sold by 1 insider under 10b5-1 plans
-
Adam S Grossman CEOPlanned sale$1.8M 147,000 shares at $12.00 6.6% of stakeTraded Nov 5 Filed Nov 5
-
Jerrold B Grossman DirectorBuy$51K 6,400 shares at $7.91 +1.2% to stakeTraded May 27 Filed May 28
-
Jerrold B Grossman DirectorBuy$100K 12,500 shares at $8.01 +2.5% to stakeTraded May 12 Filed May 14
-
Jerrold B Grossman DirectorBuy$100K 12,500 shares at $8.01 +2.6% to stakeTraded May 11 Filed May 12
-
Adam S Grossman CEOPlanned sale$318K 21,000 shares at $15.16 1% of stakeTraded Mar 16 Filed Mar 17
-
Kaitlin M. Kestenberg-Messina COOSale$158K 10,096 shares at $15.63 2.1% of stakeTraded Mar 9 Filed Mar 10
-
Steve Elms DirectorBuy$217K 14,000 shares at $15.53 +0.7% to stakeTraded Mar 5–6 Filed Mar 9
-
Adam S Grossman CEOPlanned sale$338K 21,000 shares at $16.08 0.9% of stakeTraded Feb 17 Filed Feb 17
-
Adam S Grossman CEOPlanned sale$416K 21,000 shares at $19.79 1% of stakeTraded Dec 15, 2025 Filed Dec 16, 2025
-
Adam S Grossman CEOPlanned sale$336K 21,000 shares at $16.00 1% of stakeTraded Nov 19, 2025 Filed Nov 21, 2025
-
Adam S Grossman CEOPlanned sale$336K 21,000 shares at $16.00 1% of stakeTraded Oct 24, 2025 Filed Oct 24, 2025
Also filed in the last 12 months, not counted as buying or selling: 11 option exercises, 10 share withholdings for taxes, 9 stock grants, 2 gifts, and 1 other transaction.
SEC filings
Recent issuer filings from EDGAR, 18 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 5.07 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 8.01,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| 8-K | 7.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 7.01,8.01,9.01 | Filing Doc | |
| 8-K | 2.02,5.02,9.01 | Filing Doc | |
| 10-K | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.
Further reading
As an Amazon Associate, FollowTheFilings earns from qualifying purchases.
- How to Read a Financial Report (Tracy & Tracy) View on Amazon
- Financial Statements QuickStudy Laminated Guide View on Amazon
- Financial Intelligence, Revised Ed. View on Amazon